OpenAI launches GPT-Rosalind, a reasoning model dedicated to life sciences and drug discovery

OpenAI launches GPT-Rosalind, a reasoning model for drug discovery and biological research tested by Amgen, Moderna, Thermo Fisher, and the Allen Institute.